Bundled Payment Models

The only directly relevant bundled-payment/VBC signal in the last 24 hours is renewed scrutiny of CMS’ Oncology Care Model legacy, with AJMC’s 10-year retrospective underscoring that oncology episode-based payment remains attractive but operationally difficult because drug costs, risk adjustment, attribution, and practice transformation costs can overwhelm achievable savings (AJMC special report). For ACOs, oncology groups, and payer strategists, the implication is that any next-generation oncology bundle under the Trump CMS—led by Dr. Mehmet Oz, with Abe Sutton at CMMI—will likely face pressure to tighten financial accountability while giving providers more actionable data, predictable benchmarks, and support for team-based navigation. The other items surfaced, including ASCO genomics research and Alzheimer disease care-management commentary, are clinically relevant but not new bundled-payment or Medicare/Medicaid policy developments.